Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-01-18
1991-03-19
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Lymphokine
424 90, A61K 3912, A61K 4100
Patent
active
050009516
ABSTRACT:
A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
REFERENCES:
patent: 3470294 (1969-09-01), Drager et al.
patent: 3886270 (1975-05-01), Ackermann
Gillespie, "A Study of Inactivated Distemper Virus in the Dog", pp. 3-8, Veterinary Virus Research Institute, 1964.
Bass Edmund P.
Kelsey William H.
Diamond Scientific Company
Gil Joseph C.
Nutter Nathan M.
Whalen Lyndanne M.
LandOfFree
Multivalent canine distemper virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multivalent canine distemper virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent canine distemper virus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2008968